A private biopharmaceutical company .
Neurogastrx has raised $60.0M in total funding. The most recent round was Series B. The last funding was announced in August 2021.
Neurogastrx's investors include Vivo Capital, Samsara BioCapital, OrbiMed, RTW Investments, Propel(X).
Neurogastrx is headquartered in Woburn, United States.
A private biopharmaceutical company .
Neurogastrx is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurogastrx — Funding & Investors." VCBacked, August 26, 2021, https://www.vcbacked.co/company/neurogastrx. Accessed July 20, 2026.
VCBacked. (2021). Neurogastrx — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/neurogastrx
{{cite web |title=Neurogastrx — Funding & Investors |url=https://www.vcbacked.co/company/neurogastrx |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated